![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
AM Young, MA Masaki and C Geula
Department of Psychology, Wayne State University, Detroit, Michigan.
Experiments examined how training dose of morphine modulates the agonist and antagonist effects of selected mu opioids. Saline and either 3.2 or 5.6 mg/kg morphine were established as discriminative stimuli for food-reinforced responses in two groups of rats. Etorphine and morphine evoked full morphine lever responding in both groups, but were more potent in subjects trained with 3.2 mg/kg morphine. Methadone, dezocine and dl-pentazocine were equieffective and equipotent in evoking full morphine-like stimulus effects in both groups. Nalbuphine evoked full morphine-like stimulus effects and decreased the dose of morphine required for stimulus effects in rats trained with 3.2 mg/kg morphine. In contrast, nalbuphine antagonized stimulus effects of morphine in rats trained with 5.6 mg/kg morphine, and antagonized rate-altering effects of morphine in both groups, with an apparent pA2 of 5.4 mol/kg. Nalorphine and naltrexone antagonized stimulus and rate-altering effects of morphine in both groups, with an apparent pA2 of 6.0 mol/kg for nalorphine and 7.8 mol/kg for naltrexone. For both compounds, apparent pA2 values did not discriminate between stimulus or rate-altering effects of morphine, or between training conditions. d-Amphetamine and ketamine enhanced the rate-suppressing effects of morphine. However, whereas d-amphetamine prevented stimulus effects of 3.2 mg/kg, but not 5.6 mg/kg morphine, ketamine increased sensitivity to stimulus effects of morphine in rats trained with 3.2 mg/kg morphine without altering sensitivity in rats trained with 5.6 mg/kg. These results demonstrate that training dose of morphine can modulate the likelihood that certain opioids will reproduce or antagonize discriminative stimulus effects of morphine. Furthermore, for nalbuphine and nalorphine, diminished morphine-like stimulus effects in subjects trained with the higher dose of morphine appeared to result from low efficacy mu agonist actions.
This article has been cited by other articles:
|
|
 |
|
  M. D. Recker and G. A. Higgins The Opioid Receptor Like-1 Receptor Agonist Ro 64-6198 (1S,3aS-8-2,3,3a,4,5,6-Hexahydro-1H-phenalen-1-yl-1-phenyl-1,3,8-triaza-spiro[4.5]decan-4-one) Produces a Discriminative Stimulus in Rats Distinct from That of a {micro}, {kappa}, and {delta} Opioid Receptor Agonist Cue J. Pharmacol. Exp. Ther., November 1, 2004; 311(2): 652 - 658. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. A. Walker, M. J. Picker, A. Granger, and L. A. Dykstra Effects of Opioids in Morphine-Treated Pigeons Trained to Discriminate among Morphine, the Low-Efficacy Agonist Nalbuphine, and Saline J. Pharmacol. Exp. Ther., July 1, 2004; 310(1): 150 - 158. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M. Platt, J. K. Rowlett, S. Izenwasser, and R. D. Spealman Opioid Partial Agonist Effects of 3-O-Methylnaltrexone in Rhesus Monkeys J. Pharmacol. Exp. Ther., March 1, 2004; 308(3): 1030 - 1039. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. A. Walker and A. M. Young Clocinnamox Distinguishes Opioid Agonists According to Relative Efficacy in Normal and Morphine-Treated Rats Trained to Discriminate Morphine J. Pharmacol. Exp. Ther., July 1, 2002; 302(1): 101 - 110. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. A. B. Slot and F. C. Colpaert Opiate States of Memory: Receptor Mechanisms J. Neurosci., December 1, 1999; 19(23): 10520 - 10529. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M. Platt, D. M. Grech, J. K. Rowlett, and R. D. Spealman Discriminative Stimulus Effects of Morphine in Squirrel Monkeys: Stimulants, Opioids, and Stimulant-Opioid Combinations J. Pharmacol. Exp. Ther., September 1, 1999; 290(3): 1092 - 1100. [Abstract] [Full Text]
|
|
|
|
|
|
H. E. Jones, G. E. Bigelow, and K. L. Preston Assessment of Opioid Partial Agonist Activity with a Three-Choice Hydromorphone Dose-Discrimination Procedure J. Pharmacol. Exp. Ther., June 1, 1999; 289(3): 1350 - 1361. [Abstract] [Full Text]
|
|
|
|
|
|
D. Morgan, C. D. Cook, and M. J. Picker Sensitivity to the Discriminative Stimulus and Antinociceptive Effects of µ Opioids: Role of Strain of Rat, Stimulus Intensity, and Intrinsic Efficacy at the µ Opioid Receptor J. Pharmacol. Exp. Ther., May 1, 1999; 289(2): 965 - 975. [Abstract] [Full Text]
|
|
|
|
 |
|
 D. Morgan, C. D. Cook, M. A. Smith, and M. J. Picker An Examination of the Interactions Between the Antinociceptive Effects of Morphine and Various {micro}-Opioids: The Role of Intrinsic Efficacy and Stimulus Intensity Anesth. Analg., February 1, 1999; 88(2): 407 - 407. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. S. Negus, M. B. Gatch, and N. K. Mello Discriminative Stimulus Effects of a Cocaine/Heroin "Speedball" Combination in Rhesus Monkeys J. Pharmacol. Exp. Ther., June 1, 1998; 285(3): 1123 - 1136. [Abstract] [Full Text]
|
|
|
|
|
|
M. S. Kleven and W. Koek Discriminative Stimulus Effects of 8-Hydroxy-2-(di-n-propylamino)tetralin in Pigeons and Rats: Species Similarities and Differences J. Pharmacol. Exp. Ther., January 1, 1998; 284(1): 238 - 249. [Abstract] [Full Text]
|
|
|
|
|
|
M. J. Picker Discriminative Stimulus Effects of the Mixed-Opioid Agonist/Antagonist Dezocine: Cross-Substitution by Mu and Delta Opioid Agonists J. Pharmacol. Exp. Ther., December 1, 1997; 283(3): 1009 - 1017. [Abstract] [Full Text]
|
|
|
|
|
|
H. R. Garner, T. F. Burke, C. D. Lawhorn, J. M. Stoner, and W. D. Wessinger Butorphanol-Mediated Antinociception in Mice: Partial Agonist Effects and Mu Receptor Involvement, J. Pharmacol. Exp. Ther., September 1, 1997; 282(3): 1253 - 1261. [Abstract] [Full Text]
|
|
|
|
|
|
J. P. Zacny, K. Conley, and S. Marks Comparing the Subjective, Psychomotor and Physiological Effects of Intravenous Nalbuphine and Morphine in Healthy Volunteers J. Pharmacol. Exp. Ther., March 1, 1997; 280(3): 1159 - 1169. [Abstract] [Full Text]
|
|
|
|
|
|
P. Popik and W. Danysz Inhibition of Reinforcing Effects of Morphine and Motivational Aspects of Naloxone-Precipitated Opioid Withdrawal by N-Methyl-D-aspartate Receptor Antagonist, Memantine J. Pharmacol. Exp. Ther., February 1, 1997; 280(2): 854 - 865. [Abstract] [Full Text]
|
|
 |
 |
 |
|
 |
 |
 |
